Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tarcocimab tedromer by Kodiak Sciences for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Tarcocimab tedromer is under clinical development by Kodiak Sciences and currently in Phase III for Wet (Neovascular / Exudative) Macular...
Tarcocimab tedromer by Kodiak Sciences for Non-Proliferative Diabetic Retinopathy (NPDR): Likelihood of Approval
Tarcocimab tedromer is under clinical development by Kodiak Sciences and currently in Phase III for Non-Proliferative Diabetic Retinopathy (NPDR). According...
Tarcocimab tedromer by Kodiak Sciences for Choroidal Neovascularization: Likelihood of Approval
Tarcocimab tedromer is under clinical development by Kodiak Sciences and currently in Phase III for Choroidal Neovascularization. According to GlobalData,...
Tarcocimab tedromer by Kodiak Sciences for Retinal Vein Occlusion: Likelihood of Approval
Tarcocimab tedromer is under clinical development by Kodiak Sciences and currently in Phase III for Retinal Vein Occlusion. According to...
KSI-501 by Kodiak Sciences for Diabetic Macular Edema: Likelihood of Approval
KSI-501 is under clinical development by Kodiak Sciences and currently in Phase I for Diabetic Macular Edema. According to GlobalData,...
KSI-501 by Kodiak Sciences for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
KSI-501 is under clinical development by Kodiak Sciences and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....